News

After Slashing Thousands of Jobs, Trump’s FDA Wants to Use AI to Rapidly Approve New Drugs
AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...
BioSpace1d
Makary, Prasad Lay Out Mission for FDA in Journal Kennedy Called ‘Corrupt’
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
pharmaphorum1d
Makary, Prasad set out their vision for the FDA
Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...
Fierce Biotech1d
FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
Medpage Today on MSN2d
FDA Officials Lay Out Vision for Agency
The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
BioSpace8d
FDA’s Prasad Vows To Make Rare Disease Drugs Available at ‘First Sign of Promise’
The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...
FDA plans to use AI to speed up drug and food safety reviews
The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...
FDA wants to use AI to speed up drug approval process
The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...
Becker's Hospital Review1d
FDA employs AI in effort to accelerate drug approvals
The FDA has launched a pilot program using generative AI to help expedite the review of drug and device applications, part of a sweeping modernization effort by the agency. The initiative, led by FDA ...
FDA Will Use AI to Approve Drugs and Devices Faster
The agency launched a large-language model, dubbed Elsa, just last week to streamline operations. The post FDA Will Use AI to ...
STAT3d
Pharmalittle: We’re reading about FDA and gene therapies, a kidney disease showdown, and more
Fears about the FDA imposing steep barriers to gene therapies for rare diseases appeared moot at an agency roundtable ...
BioSpace2d
As Gene Therapy Endures ‘Cold Winter,’ FDA Leaders Promise Support
Gene therapies have ridden investor mania to huge valuations but commercialization challenges have pushed market caps to the ...